Q1 2026
Read transcript →Arcus Biosciences, Inc. (RCUS) Earnings Call Transcripts
NYSE·Healthcare·Biotechnology
$26.60
-1.66%
Mkt Cap $3.40B
Q4 2025
Read transcript →Q1 2025
Read transcript →Q3 2024
Read transcript →Q1 2024
Read transcript →Q4 2023
Read transcript →Q3 2023
Read transcript →Q2 2021
Read transcript →